These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 31228441)

  • 21. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
    Falvey JD; Hoskin T; Meijer B; Ashcroft A; Walmsley R; Day AS; Gearry RB
    Inflamm Bowel Dis; 2015 Apr; 21(4):824-31. PubMed ID: 25738372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
    Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal markers: calprotectin and lactoferrin.
    Abraham BP; Kane S
    Gastroenterol Clin North Am; 2012 Jun; 41(2):483-95. PubMed ID: 22500530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases.
    Schönauen K; Le N; von Arnim U; Schulz C; Malfertheiner P; Link A
    Inflamm Bowel Dis; 2018 Jun; 24(7):1547-1557. PubMed ID: 29668922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease.
    Kolho KL; Sipponen T; Valtonen E; Savilahti E
    Int J Colorectal Dis; 2014 Jan; 29(1):43-50. PubMed ID: 24077667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.
    Diamanti A; Colistro F; Basso MS; Papadatou B; Francalanci P; Bracci F; Muraca M; Knafelz D; De Angelis P; Castro M
    Inflamm Bowel Dis; 2008 Sep; 14(9):1229-35. PubMed ID: 18398894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.
    Bodelier AG; Jonkers D; van den Heuvel T; de Boer E; Hameeteman W; Masclee AA; Pierik MJ
    Dig Dis Sci; 2017 Feb; 62(2):465-472. PubMed ID: 27933473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fecal calprotectin as a diagnostic marker of inflammatory bowel disease].
    Kostrzewska P; Całkosiński A; Majewski M; Malinowski K
    Pol Merkur Lekarski; 2022 Feb; 50(295):58-61. PubMed ID: 35278302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical value of fecal calprotectin.
    Ricciuto A; Griffiths AM
    Crit Rev Clin Lab Sci; 2019 Aug; 56(5):307-320. PubMed ID: 31088326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting.
    Mumolo MG; Bertani L; Ceccarelli L; Laino G; Di Fluri G; Albano E; Tapete G; Costa F
    World J Gastroenterol; 2018 Sep; 24(33):3681-3694. PubMed ID: 30197475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calprotectin: from biomarker to biological function.
    Jukic A; Bakiri L; Wagner EF; Tilg H; Adolph TE
    Gut; 2021 Oct; 70(10):1978-1988. PubMed ID: 34145045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of faecal calprotectin analysis in adult inflammatory bowel disease.
    Smith LA; Gaya DR
    World J Gastroenterol; 2012 Dec; 18(46):6782-9. PubMed ID: 23239916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal Calprotectin.
    Ayling RM; Kok K
    Adv Clin Chem; 2018; 87():161-190. PubMed ID: 30342711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calprotectin in inflammatory bowel disease.
    Khaki-Khatibi F; Qujeq D; Kashifard M; Moein S; Maniati M; Vaghari-Tabari M
    Clin Chim Acta; 2020 Nov; 510():556-565. PubMed ID: 32818491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of faecal eosinophil granule proteins in inflammatory bowel disease.
    Amcoff K; Cao Y; Zhulina Y; Lampinen M; Halfvarson J; Carlson M
    Scand J Gastroenterol; 2019 Oct; 54(10):1237-1244. PubMed ID: 31577465
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.